Filter posts

Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …

The Right Way to Address Prescription Drug Costs

Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City …

Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio

During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks …

Think the Drug-Pricing debate addresses Patient Costs? Think again.

Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate …

Medical Research from Mars Can Fail Patients from Venus

Historically, federal dollars inadvertently flowed to medical research with a disproportionate focus on men’s health. …

Innovative Policies Drive the Biobased Economy

This year not only marks the 25th anniversary of BIO, but this year we also …

My Pledge at World Congress: BIO Will Lead on Gene Editing

This year marks the 15th anniversary of BIO’s World Congress on Industrial Biotechnology, as well …

Rob Reiner on Addiction

“Being Charlie,” a film that educates audiences about the realities of opioid addiction and sheds …

#MakeHistory: Highlighting History | Hong Kong’s New Listing Regime

Recent announcements that the Hong Kong Stock Exchange (HKEX) plans to allow the listing of …

Innovation (at Home and in the Lab) Can Reduce Your Heart-Attack Risk

Over the last decade, I’ve become increasingly conscious of maintaining my cardiovascular health, making dietary …